Skip to main content
Premium Trial:

Request an Annual Quote

NIH Earmarks $300,000 to Support Biological Assay Development in Sickle Cell Disease

NEW YORK, Jan. 3 (GenomeWeb News) - The National Institutes of Health will award $300,000 during 2005 to advance the development of biological assays related to sickle cell disease.

 

According to the NIH, the money is expected to be used to fund three new grants under a request for applications for projects the focus on the "development of scientifically and technologically robust screening assays that can be automated and used for the identification of compounds that can be utilized in both basic research and therapeutics development programs in sickle cell disease."

 

The proposed assay protocols "must employ reagents and readouts that can be used in the high-throughput molecular screen environments," the NIH said. "Funding will be provided to enable investigators to develop and transform promising assay protocols for sickle cell disease by demonstrating the responsiveness and robustness required for use in HTS."

 

Letters of intent from RFA responders are due March 25, and applications are due April 26. Additional details about the RFA can be found  here.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.